All studies
CompletedInterventional

Neuropsychological evaluation and rehabilitation in multiple sclerosis – feasibility study

Multiple sclerosis (MS) can affect thinking, memory, and concentration. These difficulties can have a big impact on work, mood, and daily activities. The NEuRoMS study is exploring a new NHS pathway designed to spot these problems early and provide support. First, adults with MS complete brief online thinking tasks during their routine care. If the screening finds mild or moderate difficulties, participants may be invited to join a support trial. In this part, half the participants receive usual care, while the other half take part in a short programme with a therapist to learn practical coping tips. Finally, researchers will interview participants and healthcare staff to learn what worked well and what could be improved. The findings will help researchers decide if this support pathway should be tested in a much larger national trial across the UK.

At a glance

Status
Completed
Sponsor
Nottinghamshire Healthcare NHS Foundation Trust
Enrolment target
1,417
Start
01 Apr 2022
Estimated completion
31 Aug 2023

What is this study about?

Living with multiple sclerosis often involves dealing with hidden symptoms. Many people notice changes in how quickly they process information, recall everyday details, or stay focused. These memory and concentration changes can make working, managing family life, and socialising harder. Even though these difficulties affect up to 70% of people with MS, regular checks and structured support for thinking skills are not always available in routine clinic visits.

The NEuRoMS study aims to change this by creating a clear, standardised pathway within the NHS. The project introduces simple online screening tasks that clinics can use to quickly identify memory or attention issues. By spotting these difficulties early, healthcare teams hope to offer the right support before problems become more disruptive.

In this study, researchers want to see whether their support programme is practical and easy for both patients and NHS staff to use. People found to have mild or moderate thinking problems may be offered brief sessions with a healthcare professional, such as an occupational therapist or nurse. These sessions focus on practical techniques and habits to make daily tasks easier to handle.

Because this is a feasibility study, its main goal is to test the setup on a small scale at three NHS hospitals. The feedback gathered from patients and staff will show if the pathway runs smoothly and how it can be improved before launching a larger, nationwide study.

Key takeaways

  • The NEuRoMS study tests a new NHS pathway to check and support thinking and memory in people with MS.
  • Initial checks are done through short, simple online tasks.
  • Eligible participants may receive practical therapy sessions to learn daily coping tips.
  • Sessions can take place remotely via telephone or video call.
  • Taking part is completely voluntary, and you can leave the study at any time.

Who may be eligible?

This study is open to adults aged 18 and older who have been diagnosed with multiple sclerosis. Participants must be willing and able to give their consent and be able to communicate in English, as the memory and thinking tests are currently only available in English (though information sheets can be provided in Welsh on request).

To take part in the therapy sessions and interviews, you must first complete the brief online screening in Part 1 and show mild or moderate difficulties with memory or concentration. People with severe thinking challenges or those who do not show any cognitive difficulties on the screening will not be eligible for the therapy part of the study.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. I am aged 18 or over.
  2. I have a confirmed medical diagnosis of multiple sclerosis (MS).
  3. I can communicate in English to complete the online tests.
  4. I am being seen at one of the participating NHS hospital trusts (Nottingham, Cardiff, or Barts in London).
  5. I am willing to complete a brief online check of my memory and thinking.
Answer every question to see your result.

What does participation involve?

Taking part happens in stages. In the first part, you complete brief thinking and memory activities online during or around your regular MS clinic appointment. These tasks help doctors understand how common and noticeable these difficulties are.

If your results show mild or moderate difficulties, you may be invited to Part 2. In this stage, up to 80 people are randomly placed into one of two groups: one group continues with their usual NHS care, while the other takes part in a brief therapist-led programme. This programme teaches practical strategies to help manage memory and concentration problems. Sessions can be done over the telephone or by video call at a time that suits you.

In Part 3, some participants will be invited to a one-to-one interview to share their thoughts on the screening and sessions. There are no new medications involved, and your regular MS treatments will not be stopped or changed because of the study.

Potential risks and benefits

Taking part may not help your thinking skills directly, but the information you provide could help shape better NHS care for people with MS in the future. Those who receive the therapy programme may learn useful ways to cope with memory and focus problems. A possible downside is that talking about memory difficulties can sometimes feel frustrating or upsetting. If this happens, your study therapist or interviewer is trained to support you, and you will be given contact details for extra help. You can also stop any test, session, or interview at any time without giving a reason and without it affecting your normal medical care.

Locations (3)

  • The Queen’s Medical Centre
    City only
    Nottingham, England
  • University Hospital of Wales
    Approximate
    Cardiff, Wales
  • The Royal London Hospital
    Approximate
    London, England

Common questions

Will taking part affect my current MS medications?

No. This study does not test any drugs, and your usual MS treatments and clinic visits will continue as normal.

Do I have to travel to the hospital for the therapy sessions?

No. The therapy sessions and interviews can be carried out over the phone or by video call from the comfort of your home.

What happens if I find the questions or tasks upsetting?

You can take a break or stop at any point. The research team is there to support you and discuss any worries you have about your memory.

Can I choose whether I get the therapy or usual care?

No. If you qualify for Part 2, a computer system randomly decides whether you receive the support sessions or usual NHS care. This helps make the study results fair and accurate.

Do I have to pay to take part?

No. Taking part in this NHS-supported research study is completely free.

How to find out more

Roshan das Nair

Always speak to your GP or specialist before deciding to take part in a study.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.